Innovator IBD ETF Leaders ETF
LDRS
LDRS was delisted on the 13th of August, 2021.
8 hedge funds and large institutions have $1.75M invested in Innovator IBD ETF Leaders ETF in 2020 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 1 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
20% less funds holding
Funds holding: 10 → 8 (-2)
24% less capital invested
Capital invested by funds: $2.29M → $1.75M (-$538K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$160K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$34.7K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$24.5K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$7.49K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPL Financial
San Diego,
California
|
-$183K |
| 2 |
Jane Street
New York
|
-$131K |
LDRS Hedge Fund Activity: Q1 2020 in Review
8 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Innovator IBD ETF Leaders ETF (LDRS) for Q1 2020, worth a combined $1.75M — down 24% from $2.29M a quarter earlier.
Fund positioning in LDRS was balanced in Q1 2020: 1 fund opened new positions, 1 closed out, 4 added to existing stakes and 2 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $160K. The largest seller was LPL Financial, cutting an estimated $183K.
- 8 institutional investors held Innovator IBD ETF Leaders ETF (LDRS) as of Q1 2020, down from 10 in Q4 2019.
- Funds reported $1.75M of Innovator IBD ETF Leaders ETF stock for Q1 2020, down 24% quarter-over-quarter.
- 1 fund opened new Innovator IBD ETF Leaders ETF positions in Q1 2020 and 1 closed out, a net change of 0 holders.
- The largest Innovator IBD ETF Leaders ETF buyer in Q1 2020 was Susquehanna International Group, an estimated $160K added.
- The largest Innovator IBD ETF Leaders ETF seller in Q1 2020 was LPL Financial, an estimated $183K sold.
Based on aggregated 13F filings for Q1 2020.